Advertisement
Elanco Animal Health Closes Sale Of Aqua Business To Merck Animal Health
(RTTNews) - Elanco Animal Health, Inc. (ELAN) announced Tuesday it has completed the divestiture of its aqua business to Merck Animal Health (MRK) for approximately $1.3 billion in cash, with approximately $1.05 billion to $1.1 billion in net proceeds available for debt paydown in the third quarter of 2024.
The successful completion of this transaction enables the company to pay down term loan debt on a pro-rata basis per the terms of the company's credit agreements.
Combined with the expected $280 million to $320 million of cash generated from the base business, the company expects to pay down approximately $1.3 billion to $1.4 billion of debt in 2024.
read more
Elanco Animal Health Boosts FY23 Adj. EPS, Revenue Outlook As Q3 Results Top Estimates
Elanco Animal Health Inc. (ELAN) reported Tuesday a net loss for the third quarter of $1.10 billion or $2.22 per share, sharply wider than $65.0 million or $0.13 per share in the prior-year quarter.
RTTNews
|
491 days ago
Elanco's Canine Parvovirus Treatment Gets USDA License
Elanco Animal Health Inc. announced that the U.S. Department of Agriculture or USDA has issued a conditional license for its Canine Parvovirus Monoclonal Antibody. The company expects to begin shipping Canine Parvovirus Monoclonal Antibody in the coming weeks, pending individual state approvals. The targeted single-dose monoclonal antibody is the first and only approved targeted therapeutic...
RTTNews
|
679 days ago
FDA Approves First Drug For Anemia In Cats With CKD
The U.S. Food and Drug Administration conditionally approved Elanco US Inc.'s Varenzin-CA1 (molidustat oral suspension) for treating anemia in cats with chronic kidney disease or CKD. It is the first drug for the control of nonregenerative anemia associated with CKD in cats. Varenzin-CA1 works by helping to increase production of erythropoietin in the kidney, which in turn stimulates the bone mar
RTTNews
|
680 days ago
ECB Chief Says Uncertainty Exceptionally High
European Central Bank President Christine Lagarde said the level of uncertainty is exceptionally high and maintaining stability has become difficult. "The level of uncertainty we are facing is exceptionally high," she said at a conference organized by the Institute for Monetary and Financial Stability at Goethe University Frankfurt on Wednesday.
RTTNews
|
4h 31min ago
Yen Falls Amid Risk-on Mood
The Japanese yen weakened against other major currencies in the European session on Wednesday, as European shares traded higher after Ukraine signaled its readiness to accept a U.S. proposal for an "immediate, interim 30-day ceasefire" with Russia, and the European Union announced retaliatory tariffs on U.S. imports of steel and aluminum.
RTTNews
|
4h 51min ago
PUMA Stock Plunges On Weak Outlook, Dividend Cut, Despite Upbeat Q4
Shares of Puma SE were sinking more than 24 percent in the morning trading in Germany after the sportswear maker on Wednesday warned on weak earnings in its first quarter and fiscal 2025 and trimmed dividend, despite reporting significantly higher profit in its fourth quarter with strong sales.
RTTNews
|
4h 59min ago
Sensex, Nifty End Marginally Lower; IT Stocks Hit Hard
Indian shares fluctuated before ending on a flat note Wednesday.
RTTNews
|
5h 40min ago
FTSE 100 Moderately Higher As Stocks Recover From Recent Losses
U.K. stocks are up after six successive days of declines, with shares from the mining sector contributing significantly to the gains Wednesday morning.
Optimism over a ceasefire in Ukraine is aiding sentiment.
RTTNews
|
5h 48min ago
